ERBB2 and breast cancer: In contrast, Chinese patients with locally recurrent or metastatic HER2-positive breast cancer in the PUFFIN study appeared to have a lower incidence of febrile neutropenia than reported here and in the Asian and overall population in the CLEOPATRA study [21].